tirzepatide dosing chart Microdosing Chart: A Weekly Dose Guide That Works The infographic compares 10 commonly

The oral GLP-1 therapies segment held 8% of the market share in 2025 and is expected to grow at the fastest CAGR of 21.8% during the forecast period

Weight loss drugs have gained significant traction due to their promise of rapid results

Cold injections sting more and can cause more localized irritation

Sources Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C Eli Lilly and Company July 23, 2026 A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2) National Library of Medicine April 13, 2026 A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3) National Library of Medicine May 22, 2026,

Water retention Low metabolism What is the best time of day to inject semaglutide

From there, the weekly check-in becomes the core of the experience